These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21239045

  • 1. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
    Feng Z, Fan X, Jiao Y, Ban K.
    Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
    [Abstract] [Full Text] [Related]

  • 2. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
    Wang QM, Jia LQ, Zhou HY, Li YS.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
    [Abstract] [Full Text] [Related]

  • 3. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH, Sun X, Meng XW, Lv ZW, Du YJ, Zhu Y, Chen J, Kong DX, Jin SZ.
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F.
    Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
    [Abstract] [Full Text] [Related]

  • 5. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [Abstract] [Full Text] [Related]

  • 6. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY, Su CC, Kuo WW, Yeh YL, Kuo WH, Tsai FJ, Tsai CH, Weng YJ, Huang CY, Chen LM.
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [Abstract] [Full Text] [Related]

  • 7. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA.
    Cancer Res; 2007 Feb 01; 67(3):901-10. PubMed ID: 17283120
    [Abstract] [Full Text] [Related]

  • 8. [The role and significance of Wnt/beta-catenin signaling pathway regulating the signaling molecules in hepatocellular carcinoma].
    Wang XH, Sun X, Meng XW, Lü ZW, Liu MN, Pei FH.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep 01; 18(9):672-5. PubMed ID: 20943078
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH.
    J Thorac Cardiovasc Surg; 2012 Dec 01; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [Abstract] [Full Text] [Related]

  • 10. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 01; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 11. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH, Hong JJ, Guo SY, Yang RL, Yuan J, Wen CY, Zhou KY, Li CJ.
    Cell Res; 2004 Feb 01; 14(1):74-80. PubMed ID: 15040893
    [Abstract] [Full Text] [Related]

  • 12. Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma.
    Guo Y, Liang X, Lu M, Weng T, Liu Y, Ye X.
    Hepatogastroenterology; 2010 Feb 01; 57(101):913-8. PubMed ID: 21033251
    [Abstract] [Full Text] [Related]

  • 13. mTOR and P70 S6 kinase expression in primary liver neoplasms.
    Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8421-5. PubMed ID: 15623621
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
    Fujito T, Sasaki Y, Iwao K, Miyoshi Y, Yamada T, Ohigashi H, Ishikawa O, Imaoka S.
    Hepatogastroenterology; 2004 Dec 15; 51(58):921-4. PubMed ID: 15239213
    [Abstract] [Full Text] [Related]

  • 15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA.
    Cancer Res; 2009 May 01; 69(9):3764-71. PubMed ID: 19383900
    [Abstract] [Full Text] [Related]

  • 16. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
    Bae SH, Jung ES, Park YM, Jang JW, Choi JY, Cho SH, Yoon SK, Ahn BM, Cha SB, Chung KW, Sun HS, Park DH, Kim BK, Kim DG.
    Taehan Kan Hakhoe Chi; 2002 Sep 01; 8(3):297-303. PubMed ID: 12499787
    [Abstract] [Full Text] [Related]

  • 17. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K.
    Clin Cancer Res; 2002 Feb 01; 8(2):450-6. PubMed ID: 11839663
    [Abstract] [Full Text] [Related]

  • 18. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C, Liu QG, Yang W, Zhang ZL, Yao YM.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 01; 7(5):490-6. PubMed ID: 18842495
    [Abstract] [Full Text] [Related]

  • 19. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
    Lee HS, Park MH, Yang SJ, Park KC, Kim NS, Kim YS, Kim DI, Yoo HS, Choi EJ, Yeom YI.
    Life Sci; 2007 Jan 23; 80(7):690-8. PubMed ID: 17157329
    [Abstract] [Full Text] [Related]

  • 20. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W.
    J Hepatol; 2009 May 23; 50(5):948-57. PubMed ID: 19303159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.